The D1CT-7 mouse model of Tourette syndrome displays sensorimotor gating deficits in response to spatial confinement

British Journal of Pharmacology

Volumn , Issue , 2016, Pages 2111-2121

  Godar, Sean C ^a   Mosher, Laura J ^a   Strathman, Hunter J ^a   Gochi, Andrea M ^c   Jones, Cori M ^a   Fowler, Stephen C ^a   Bortolato, Marco ^a,b  

^a UNIVERSITY OF KANSAS   (United States)

^b UNIVERSITY OF KANSAS   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; CLONIDINE; CORTICOSTERONE; HALOPERIDOL;

AGGRESSION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; D1CT 7 MICE; ENVIRONMENTAL STRESS; EXPLORATORY BEHAVIOR; FEMALE; GILLES DE LA TOURETTE SYNDROME; INFANT; MALE; MOUSE; MOUSE MODEL; MOUSE STRAIN; NONHUMAN; OPEN FIELD BEHAVIOR; PATHOPHYSIOLOGY; PREPULSE INHIBITION; PRIORITY JOURNAL; SENSORY GATING; SOCIAL INTERACTION; STARTLE REFLEX; TIC; WILD TYPE;

EID: 84976568154     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.13243     Document Type: Article

References (51)

1. Abercrombie ED, Keefe KA, DiFrischia DS, Zigmond MJ (1989). Differential effect of stress on in vivo dopamine release in striatum, nucleus accumbens, and medial frontal cortex. J Neurochem 52: 1655–1658.
2. Ahmari SE, Spellman T, Douglass NL, Kheirbek MA, Simpson HB, Deisseroth K et al. (2013). Repeated cortico-striatal stimulation generates persistent OCD-like behavior. Science 340: 1234–1239.
3. Albin RL, Mink JW (2006). Recent advances in Tourette syndrome research. Trends Neurosci 29: 175–182.
4. Alexander SP, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M et al. (2013). The concise guide to PHARMACOLOGY 2013/14: G protein-coupled receptors. Br J Pharmacol 170: 1459–1581.
5. Bohlhalter S, Goldfine A, Matteson S, Garraux G, Hanakawa T, Kansaku K et al. (2006). Neural correlates of tic generation in Tourette syndrome: an event-related functional MRI study. Brain 129: 2029–2037.
6. Bortolato M, Godar SC, Melis M, Soggiu A, Roncada P, Casu A et al. (2012). NMDARs mediate the role of monoamine oxidase A in pathological aggression. J Neurosci 32: 8574–8582.
7. Braff DL, Geyer MA, Swerdlow NC (2001). Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berl) 156: 234–258.
8. Budman CL, Rockmore L, Stokes J, Sossin M (2003). Clinical phenomenology of episodic rage in children with Tourette syndrome. J Psychosom Res 55: 59–65.
9. Campbell KM, de Lecea L, Severynse DM, Caron MG, McGrath MJ, Sparber SB et al. (1999a). OCD-like behaviors caused by a neuropotentiating transgene targeted to cortical and limbic D1+ neurons. J Neurosci 19: 5044–5053.
10. Campbell KM, McGrath MJ, Burton FH (1999b). Differential response of cortical-limbic neuropotentiated compulsive mice to D1 and D2 antagonists. Eur J Pharmacol 371: 103–111.
11. Castellanos FX, Fine EJ, Kaysen D, Marsh WL, Rapoport JL, Hallett M (1996). Sensorimotor gating in boys with Tourette's syndrome and ADHD: preliminary results. Biol Psychiatry 39: 33–41.
12. Chartoff EH, Marck BT, Matsumoto AM, Dorsa DM, Palmiter RD (2001). Induction of stereotypy in dopamine-deficient mice requires striatal D1 receptor activation. Proc Natl Acad Sci USA 98: 10451–10456.
13. Church JA, Schlaggar BL (2014). Pediatric Tourette syndrome: insights from recent neuroimaging studies. J Obsessive Compuls Relat Disord 3: 386–393.
14. Cohen DJ, Young JG, Nathanson JA, Shaywitz BA (1979). Clonidine in Tourette's syndrome. Lancet 2: 551–553.
15. Cohen SC, Leckman JF, Bloch MH (2013). Clinical assessment of Tourette syndrome and tic disorders. Neurosci Biobehav Rev 37: 997–1007.
16. Cole BJ, Cador M, Stinus L, Rivier J, Vale W, Koob GF et al. (1990). Central administration of a CRF antagonist blocks the development of stress-induced behavioral sensitization. Brain Res 512: 343–346.
17. Conelea CA, Woods DW (2008). The influence of contextual factors on tic expression in Tourette's syndrome: a review. J Psychosom Res 65: 487–496.
18. Dews PB (1991). Stereotypy and asymmetry in mice. J Neural Transm Suppl 34: 211–216.
19. Finlay JM, Zigmond MJ, Abercrombie ED (1995). Increased dopamine and norepinephrine release in medial prefrontal cortex induced by acute and chronic stress: effects of diazepam. Neuroscience 64: 619–628.
20. Fowler SC, Birkestrand BR, Chen R, Moss SJ, Vorontsova E, Wang G et al. (2001). A force-plate actometer for quantitating rodent behaviors: illustrative data on locomotion, rotation, spatial patterning, stereotypies, and tremor. J Neurosci Methods 107: 107–124.
21. Fowler SC, Covington HE 3rd, Miczek KA (2007). Stereotyped and complex motor routines expressed during cocaine self-administration: results from a 24-h binge of unlimited cocaine access in rats. Psychopharmacology (Berl) 192: 465–478.
22. Frau R, Pillolla G, Bini V, Tambaro S, Devoto P, Bortolato M (2013). Inhibition of 5alpha-reductase attenuates behavioral effects of D1-, but not D2-like receptor agonists in C57BL/6 mice. Psychoneuroendocrinology 38: 542–551.
23. Garner JP, Mason GJ (2002). Evidence for a relationship between cage stereotypies and behavioural disinhibition in laboratory rodents. Behav Brain Res 136: 83–92.
24. Gilbert DL, Budman CL, Singer HS, Kurlan R, Chipkin RE (2014). A D1 receptor antagonist, ecopipam, for treatment of tics in Tourette syndrome. Clin Neuropharmacol 37: 26–30.
25. Glick SD, Carlson JN, Baird JL, Maisonneuve IM, Bullock AE (1988). Basal and amphetamine-induced asymmetries in striatal dopamine release and metabolism: bilateral in vivo microdialysis in normal rats. Brain Res 473: 161–164.
26. Godar SC, Bortolato M, Frau R, Dousti M, Chen K, Shih JC (2011). Maladaptive defensive behaviours in monoamine oxidase A-deficient mice. Int J Neuropsychopharmacol 14: 1195–1207.
27. Godar SC, Mosher LJ, Di Giovanni G, Bortolato M (2014). Animal models of tic disorders: a translational perspective. J Neurosci Methods 238: 54–69.
28. Haraguchi K, Ito K, Kotaki H, Sawada Y, Iga T (1997). Prediction of drug-induced catalepsy based on dopamine D1, D2, and muscarinic acetylcholine receptor occupancies. Drug Metab Dispos 25: 675–684.
29. Holmes A, Crawley JN (2000). Prombehaviours and limitations of transgenic and knockout mice in modeling psychiatric symptoms. In: Myslobodsky MS, Weiner I (eds). Contemporary Issues in Modeling Psychopathology. Kluwer Academic Publishers: Norwell, MA, pp. 55–77.
30. Jankovic J (2001). Tourette's syndrome. N Engl J Med 345: 1184–1192.
31. Jiménez-Jiménez FJ, García-Ruiz PJ (2001). Pharmacological options for the treatment of Tourette's disorder. Drugs 61: 2207–2220.
32. Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG (2010). Animal research: reporting in vivo experiments: the ARRIVE guidelines. Br J Pharmacol 160: 1577–1579.
33. Lutz C, Well A, Novak M (2003). Stereotypic and self-injurious behavior in rhesus macaques: a survey and retrospective analysis of environment and early experience. Am J Primatol 60: 1–15.
34. McGrath MJ, Campbell KM, Burton FH (1999). The role of cognitive and affective processing in a transgenic mouse model of cortical-limbic neuropotentiated compulsive behavior. Behav Neurosci 113: 1249–1256.
35. McGrath J, Drummond G, McLachlan E, Kilkenny C, Wainwright C (2010). Guidelines for reporting experiments involving animals: the ARRIVE guidelines. Br J Pharmacol 160: 1573–1576.
36. Nordstrom EJ, Burton FH (2002). A transgenic model of comorbid Tourette's syndrome and obsessive-compulsive disorder circuitry. Mol Psychiatry 7: 617–625.
37. Pawson AJ, Sharman JL, Benson HE, Faccenda E, Alexander SP, Buneman OP et al.; NC-IUPHAR (2014). The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands. Nucl Acids Res 42 (Database Issue): D1098–D1106.
38. Popoli M, Yan Z, McEwen BS, Sanacora G (2011). The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission. Nat Rev Neurosci 13: 22–37.
39. Ralph-Williams RJ, Lehmann-Masten V, Geyer MA (2003). Dopamine D1 rather than D2 receptor agonists disrupt prepulse inhibition of startle in mice. Neuropsychopharmacology 28: 108–118.
40. Robertson MM (2000). Tourette syndrome, associated conditions and the complexities of treatment. Brain 123: 425–462.
41. Sabban EL, Kvetnanský R (2001). Stress-triggered activation of gene expression in catecholaminergic systems: dynamics of transcriptional events. Trends Neurosci 24: 91–98.
42. Scahill LD, Leckman JF, Marek KL (1995). Sensory phenomena in Tourette's syndrome. Adv Neurol 65: 273–280.
43. Silva RR, Munoz DM, Daniel W, Barickman J, Friedhoff AJ (1996). Causes of haloperidol discontinuation in patients with Tourette's disorder management and alternatives. J Clin Psychiatry 57: 129–135.
44. Simon P, Dupuis R, Costentin J (1994). Thigmotaxis as an index of anxiety in mice. Influence of dopaminergic transmissions. Behav Brain Res 61: 59–64.
45. Singer HS (2013). Motor control, habits, complex motor stereotypies, and Tourette syndrome. Ann N Y Acad Sci 1304: 22–31.
46. Stephens RJ, Sandor P (1999). Aggressive behaviour in children with Tourette syndrome and comorbid attention-deficit hyperactivity disorder and obsessive-compulsive disorder. Can J Psychiatry 44: 1036–1042.
47. Swerdlow NC, Sutherland AN (2006). Preclinical models relevant to Tourette syndrome. Adv Neurol 99: 69–88.
48. Swerdlow NC, Karban B, Ploum Y, Sharp R, Geyer MA, Eastvold A (2001). Tactile prepuff inhibition of startle in children with Tourette's syndrome: in search of an ‘fMRI-friendly’ startle paradigm. Biol Psychiatry 50: 578–585.
49. Tan CM, Wilson MH, MacMillan LB, Kobilka BK, Limbird LE (2002). Heterozygous alpha 2A-adrenergic receptor mice unveil unique therapeutic benefits of partial agonists. Proc Natl Acad Sci USA 99: 12471–12476.
50. Wang Z, Maia TV, Marsh R, Colibazzi T, Gerber A, Peterson BS (2011). The neural circuits that generate tics in Tourette's syndrome. Am J Psychiatry 168: 1326–1337.
51. Wemelsfelder F (1990). Boredom and laboratory animal welfare. In: Rollin BE (ed.). The Experimental Animal in Biomedical Research. CRC-Press: Boca Raton, FL, pp. 243–269.